Jacob Vorstman is associate professor of psychiatry at the University of Toronto and director of the Autism Research Unit at the Hospital for Sick Children in Canada. Initially, his research focused on the psychiatric and genetic aspects of the 22q11.2 deletion. After obtaining his Ph.D. in 2008, he broadened the scope from 22q11.2 deletion syndrome to the study of genotype-phenotype relations in neurodevelopmental conditions — in particular, autism, intellectual disability and schizophrenia. His ambition is to further insights into the genetic architecture underlying these conditions as well as to improve methods to measure the associated phenotypes.

Jacob Vorstman
Professor
The Hospital for Sick Children
From this contributor
A genetics-first clinic for catching developmental conditions early: Q&A with Jacob Vorstman
A new clinic is assessing children who have a genetic predisposition for autism and other neurodevelopmental conditions—sometimes before traits appear.

A genetics-first clinic for catching developmental conditions early: Q&A with Jacob Vorstman
How polygenic scores can improve predictions about autism, schizophrenia
Jacob Vorstman wants to help people who have rare mutations tied to autism, schizophrenia and other neurodevelopmental conditions set expectations about outcomes.

How polygenic scores can improve predictions about autism, schizophrenia
Explore more from The Transmitter
Mitochondrial ‘landscape’ shifts across human brain
Evolutionarily newer regions sport mitochondria with a higher capacity for energy production than older regions, according to the first detailed map of the organelles in a tissue slice, adding to mounting evidence that the brain features a metabolic gradient.

Mitochondrial ‘landscape’ shifts across human brain
Evolutionarily newer regions sport mitochondria with a higher capacity for energy production than older regions, according to the first detailed map of the organelles in a tissue slice, adding to mounting evidence that the brain features a metabolic gradient.
Expediting clinical trials for profound autism: Q&A with Matthew State
Aligning Research to Impact Autism, a new initiative funded by the Sergey Brin Family Foundation, wants to bring basic science discoveries to the clinic faster.

Expediting clinical trials for profound autism: Q&A with Matthew State
Aligning Research to Impact Autism, a new initiative funded by the Sergey Brin Family Foundation, wants to bring basic science discoveries to the clinic faster.
This paper changed my life: Shane Liddelow on two papers that upended astrocyte research
A game-changing cell culture method developed in Ben Barres’ lab completely transformed the way we study astrocytes and helped me build a career studying their reactive substates.

This paper changed my life: Shane Liddelow on two papers that upended astrocyte research
A game-changing cell culture method developed in Ben Barres’ lab completely transformed the way we study astrocytes and helped me build a career studying their reactive substates.